241 related articles for article (PubMed ID: 35387504)
1. Effect of chronic hydroxychloroquine use on COVID-19 risk in patients with rheumatoid arthritis and systemic lupus erythematosus: a multicenter retrospective cohort.
Walbi IA; Albarqi HA; Alghanim NS; Albadi MA; Al Maimouni HM; Alkahtani SA; Alshabi AM; Alali AS; Alqahtani F; Al-Najjar AH; Hazzazi MA; Alanazi DS; Sabei AA; Alsaweed OS; Alajra RK; Alqhtani H
J Int Med Res; 2022 Apr; 50(4):3000605221090363. PubMed ID: 35387504
[TBL] [Abstract][Full Text] [Related]
2. Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: a population-based cohort study.
Jung SY; Kim MS; Kim MC; Choi SH; Chung JW; Choi ST
Clin Microbiol Infect; 2021 Apr; 27(4):611-617. PubMed ID: 33316402
[TBL] [Abstract][Full Text] [Related]
3. Risk of Arrhythmia Among New Users of Hydroxychloroquine in Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population-Based Study.
Hoque MR; Lu L; Daftarian N; Esdaile JM; Xie H; Aviña-Zubieta JA
Arthritis Rheumatol; 2023 Mar; 75(3):475-484. PubMed ID: 36054570
[TBL] [Abstract][Full Text] [Related]
4. How toxic is an old friend? A review of the safety of hydroxychloroquine in clinical practice.
Fairley JL; Nikpour M; Mack HG; Brosnan M; Saracino AM; Pellegrini M; Wicks IP
Intern Med J; 2023 Mar; 53(3):311-317. PubMed ID: 35969110
[TBL] [Abstract][Full Text] [Related]
5. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus.
Wolfe F; Marmor MF
Arthritis Care Res (Hoboken); 2010 Jun; 62(6):775-84. PubMed ID: 20535788
[TBL] [Abstract][Full Text] [Related]
6. Hydroxychloroquine safety: A meta-analysis of randomized controlled trials.
Eljaaly K; Alireza KH; Alshehri S; Al-Tawfiq JA
Travel Med Infect Dis; 2020; 36():101812. PubMed ID: 32645478
[TBL] [Abstract][Full Text] [Related]
7. Hydroxychloroquine Use and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis.
Jorge A; Lu N; Choi H; Esdaile JM; Lacaille D; Avina-Zubieta JA
Arthritis Care Res (Hoboken); 2023 Apr; 75(4):743-748. PubMed ID: 34941008
[TBL] [Abstract][Full Text] [Related]
8. Baseline use of hydroxychloroquine or immunosuppressive drugs and the risk of coronavirus disease 2019.
Kim JW; Kwak SG; Lee H; Kim SK; Choe JY; Park SH
Korean J Intern Med; 2022 May; 37(3):673-680. PubMed ID: 33706472
[TBL] [Abstract][Full Text] [Related]
9. Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus.
Penn SK; Kao AH; Schott LL; Elliott JR; Toledo FG; Kuller L; Manzi S; Wasko MC
J Rheumatol; 2010 Jun; 37(6):1136-42. PubMed ID: 20436082
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 in patients with rheumatological diseases in the Eastern Province of Saudi Arabia.
Alqatari S; Nemer A; Hasan M; Bukhari R; Al Argan R; Al Khafaji D; Alwaheed A; Alzaki A; Al-Wazza M; Al Warthan S; Al Saeed A; Albeladi F; Almeer H; AlSulaiman R; Abu Quren A
J Med Life; 2023 Jun; 16(6):873-882. PubMed ID: 37675163
[TBL] [Abstract][Full Text] [Related]
11. Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy.
Abarientos C; Sperber K; Shapiro DL; Aronow WS; Chao CP; Ash JY
Expert Opin Drug Saf; 2011 Sep; 10(5):705-14. PubMed ID: 21417950
[TBL] [Abstract][Full Text] [Related]
12. Incidence of COVID-19 in patients under chronic treatment with hydroxychloroquine.
Tejada Cifuentes F; Lloret Callejo Á; Tirado Peláez MJ; Rubio Pulido O; Ruiz-Morote Aragón M; Fernández Urrusuno R; Muñoz Carreras MI; Méndez Esteban MI; Maestre Sánchez V; García Bonilla A; Paredero Dominguez JM; Arroyo Pineda V; Marco Tejón E; Romero Candel G; Fernández Marchante AI; Marco Del Rio J; Ortiz Martín T; López Sánchez P
Med Clin (Barc); 2021 Feb; 156(4):166-171. PubMed ID: 33308853
[TBL] [Abstract][Full Text] [Related]
13. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
[TBL] [Abstract][Full Text] [Related]
14. Skin and ophthalmic complications of chloroquine and hydroxychloroquine in patients with rheumatoid arthritis and systemic lupus erythematous.
Zamani B; Hasan-Abad AM; Rafizadeh SM; Akbari H; Motedayyen H
J Immunoassay Immunochem; 2024 May; 45(3):178-188. PubMed ID: 38722204
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus.
Vázquez-Otero I; Medina-Cintrón N; Arroyo-Ávila M; González-Sepúlveda L; Vilá LM
Lupus Sci Med; 2020 May; 7(1):. PubMed ID: 32434863
[TBL] [Abstract][Full Text] [Related]
16. Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study.
Fernandez-Ruiz R; Bornkamp N; Kim MY; Askanase A; Zezon A; Tseng CE; Belmont HM; Saxena A; Salmon JE; Lockshin M; Buyon JP; Izmirly PM
Arthritis Res Ther; 2020 Aug; 22(1):191. PubMed ID: 32807233
[TBL] [Abstract][Full Text] [Related]
17. Continuation Rate, Safety and Efficacy of Hydroxychloroquine Treatment in a Retrospective Cohort of Systemic Lupus Erythematosus in a Japanese Municipal Hospital.
Hosokawa Y; Oiwa H
Intern Med; 2020 Oct; 59(20):2485-2490. PubMed ID: 32641656
[TBL] [Abstract][Full Text] [Related]
18. Retinal toxicity related to hydroxychloroquine in patients with systemic lupus erythematosus and rheumatoid arthritis.
Telek HH; Yesilirmak N; Sungur G; Ozdemir Y; Yesil NK; Ornek F
Doc Ophthalmol; 2017 Dec; 135(3):187-194. PubMed ID: 28852896
[TBL] [Abstract][Full Text] [Related]
19. Association of Hydroxychloroquine Use With Decreased Incident Atrial Fibrillation in Systemic Lupus Erythematosus.
Gupta A; Shields KJ; Manzi S; Wasko MC; Sharma TS
Arthritis Care Res (Hoboken); 2021 Jun; 73(6):828-832. PubMed ID: 33098269
[TBL] [Abstract][Full Text] [Related]
20. The Pharmacological Mechanisms and Therapeutic Activities of Hydroxychloroquine in Rheumatic and Related Diseases.
Hu C; Lu L; Wan JP; Wen C
Curr Med Chem; 2017; 24(20):2241-2249. PubMed ID: 28302011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]